Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that researchers will present new data from a retrospective, multinational natural history study of children with hypophosphatasia (HPP) (symptom onset =6 months to <18 years) in two separate late-breaking presentations at the Endocrine Society’s 97th Annual Meeting and Expo (ENDO). Abstracts summarizing these presentations are published on the ENDO website and can be accessed using the links below. The ENDO annual meeting will be held March 5-8, 2015, in San Diego.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
